| 1996 |
Cytohesin-1 specifically interacts with the intracellular portion of the integrin β2 chain (CD18) and overexpression of full-length cytohesin-1 or its SEC7 domain induces β2 integrin-dependent binding of Jurkat cells to ICAM-1, while expression of the isolated PH domain inhibits T cell receptor-stimulated adhesion. |
Co-interaction assay with integrin β2 cytoplasmic domain; overexpression and dominant-negative studies in Jurkat cells measuring ICAM-1 adhesion |
Cell |
High |
8706128
|
| 1997 |
Cytohesin-1 functions as a guanine nucleotide-exchange protein (GEP) for ARF GTPases, accelerating GDP-to-GTP exchange on ARF1 and ARF3 purified from bovine brain; this GEP activity is not inhibited by brefeldin A, distinguishing it from BFA-sensitive ARF-GEPs. |
In vitro GEP assay with recombinant cytohesin-1 (expressed in E. coli) and purified ARF; [35S]GTPγS binding and [3H]GDP release assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
9050849
|
| 1998 |
Constitutively active PI 3-kinase is sufficient to activate Jurkat cell adhesion to ICAM-1 and induces membrane recruitment of cytohesin-1; this effect requires the cytohesin-1 PH domain, placing PI 3-kinase upstream of cytohesin-1 in the β2 integrin inside-out signaling pathway. |
Overexpression of constitutively active PI 3-kinase; dominant-negative PH domain constructs; membrane fractionation to assess cytohesin-1 localization; adhesion assays |
The Journal of biological chemistry |
High |
9614087
|
| 1998 |
Both the PH domain and the adjacent C-terminal polybasic (c) domain of cytohesin-1 are required together for high-affinity (100 nM) binding to PI(3,4,5)P3 and for plasma membrane association and biological function; the isolated PH domain has substantially lower affinity (~2–3 µM) for PI(3,4,5)P3. |
Biosensor affinity measurements; deletion/chimeric mutant expression in Jurkat cells; membrane association assays; functional adhesion assays |
Molecular biology of the cell |
High |
9693361
|
| 1998 |
NMR solution structure of the cytohesin-1 Sec7 domain reveals 10 α-helices forming a unique fold; ARF1 binding occurs through a large surface on the C-terminal subdomain involving hydrophobic and polar residues; structure-based mutagenesis identified residues critical for ARF binding and nucleotide exchange. However, the Sec7 domain and the β2 integrin cytoplasmic domain do not interact in solution phase. |
NMR spectroscopy; 1H-15N and 1H-13C chemical shift perturbation mapping; structure-based mutagenesis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
9653114
|
| 1998 |
The cytohesin-1 Sec7 domain catalyzes guanine nucleotide exchange on ARFs 1, 5, and 6, yeast ARFs 1–3, and ARD1; full-length cytohesin-1 shows narrower substrate specificity (active on ARF1, ARF3, and ARD1 but not ARF5/6), indicating that regions outside the Sec7 domain contribute to substrate specificity. Neither acts on ARF-like (ARL) proteins. |
In vitro GTPγS binding assays with purified recombinant proteins; comparison of Sec7 domain alone vs. full-length cytohesin-1 across a panel of ARF/ARL substrates |
The Journal of biological chemistry |
High |
9756891
|
| 1999 |
Cytohesin-1 PH domain binds the inositol head group of PI(3,4,5)P3 (as IP4) with >200-fold higher affinity than PI(4,5)P2 or PI(3,4)P2 in vitro; EGF- or NGF-stimulated translocation of GFP-cytohesin-1 from cytosol to plasma membrane in PC12 cells requires PI 3-kinase activity and an intact PH domain. |
In vitro PH domain-lipid binding assays; GFP-cytohesin-1 live-cell confocal microscopy in PC12 cells; wortmannin/LY294002 inhibition; dominant-negative p85 co-expression |
Journal of cell science |
High |
10341214
|
| 1999 |
Structural elements in ARF1 required for functional interaction with cytohesin-1 include the N-terminal α-helix (residues 1–13), switch 1 region (residues 28–50, including Lys-38), and C-terminal region (last 42 amino acids); replacing Lys-38 with Gln abolishes the interaction with both cytohesin-1 and its Sec7 domain. |
ARF1/ARL1 chimeric protein panel; site-directed mutagenesis; in vitro [35S]GTPγS binding assays |
The Journal of biological chemistry |
High |
10212218
|
| 1999 |
Cytohesin-1 is required for LPS-induced β2 integrin (LFA-1)-mediated monocyte adherence to ICAM-1 downstream of CD14, Rho, and PI 3-kinase; antisense knockdown of cytohesin-1 abrogates LPS-induced adherence without affecting LFA-1 surface expression. |
Cytohesin-1 antisense oligonucleotides in THP-1/CD14 cells; PI 3-kinase inhibitors; Toxin B (Rho inhibitor); ICAM-1 adhesion assays |
The Journal of biological chemistry |
Medium |
9873050
|
| 2000 |
Cytohesin-1 regulates β2 integrin adhesion through two separable mechanisms: (1) direct interaction with the LFA-1 β2 cytoplasmic domain activates an extracellular epitope of LFA-1 independent of ARF-GEF activity; (2) ARF-GEF activity is required for LFA-1-mediated cell spreading on ICAM-1. A GEF-dead mutant of cytohesin-1 blocks spreading but not initial LFA-1 activation. |
Mutational analysis of β2 cytoplasmic domain; cytohesin-1 GEF-dead mutant (E157K); in vitro ARF GDP-GTP exchange assays; LFA-1 activation epitope detection; cell adhesion and spreading assays |
The EMBO journal |
High |
10835351
|
| 2000 |
PI(3,4,5)P3 differentially regulates cytohesin-1 GEF specificity: it suppresses cytohesin-1-dependent GTP binding to ARF6-Ig chimeras while enhancing GTP binding to ARF1-Ig chimeras, thereby switching ARF substrate specificity of cytohesin-1. |
In vitro GTP-binding assays using immunoprecipitated ARF1-Ig and ARF6-Ig chimeras from mammalian cells; addition of purified phosphoinositides |
European journal of biochemistry |
Medium |
10848997
|
| 2000 |
Cytohesin-1 specifically accelerates GTPγS binding to ARD1 (a 64-kDa lysosomal/Golgi GTPase) but not cytohesin-2; the specificity is determined by residue 30 in the Sec7 domain and the ARD1 effector region; in COS-7 cells, overexpressed ARD1 and cytohesin-1 partially colocalize. |
Yeast two-hybrid screen (ARD1 as bait); in vitro [35S]GTPγS binding assays; Sec7 domain point mutagenesis; confocal fluorescence microscopy of co-transfected COS-7 cells |
The Journal of biological chemistry |
Medium |
10748148
|
| 2000 |
B2-1/cytohesin-1 localizes to the Golgi complex (not primarily the plasma membrane) under endogenous expression conditions; this Golgi association is disrupted by brefeldin A; overexpression of GFP-B2-1 shows Golgi targeting and excessive overexpression causes partial Golgi dispersion. |
Immunofluorescence localization; brefeldin A treatment; transient transfection of GFP-tagged B2-1; confocal microscopy |
Experimental cell research |
Medium |
10772823
|
| 2001 |
Protein kinase Cδ phosphorylates a serine/threonine motif within the C-terminal polybasic domain of cytohesin-1 in vitro; phorbol ester stimulation also induces phosphorylation of these residues in vivo; PKC-phosphorylated cytohesin-1 associates tightly with the actin cytoskeleton and phosphorylation is required for maximal LFA-1-mediated Jurkat cell adhesion to ICAM-1. |
In vitro kinase assay with purified PKCδ; phorbol ester stimulation in vivo; co-sedimentation with actin cytoskeleton; site-directed mutagenesis; adhesion assays |
The Journal of biological chemistry |
High |
11438522
|
| 2001 |
Human herpesvirus 8 kaposin A directly interacts with cytohesin-1 and recruits it to the membrane; this interaction mediates kaposin A-induced focus formation, stress fiber dissolution, and ERK-1/2 MAP kinase activation; these effects are reversed by the GEF-dead cytohesin-1 E157K mutant; liposome-embedded kaposin A specifically stimulates cytohesin-1-dependent GTP binding to myristoylated ARF1 in vitro. |
Co-immunoprecipitation; dominant-negative GEF mutant (E157K) rescue; in vitro ARF GTP-binding assay with liposome-embedded kaposin A; focus formation and stress fiber assays |
Molecular cell |
High |
11336706
|
| 2001 |
Cytohesin-1 overexpression increases LFA-1-dependent leukocyte arrest triggered by chemokines on cytokine-activated endothelium; the PH domain (not GEF activity) mediates firm arrest, while both LFA-1 interaction and GEF activity are required for shape change and transendothelial chemotaxis; ARF6 (but not ARF1) participates as downstream GEF target in chemotaxis. |
Overexpression and dominant-negative constructs (PH domain, GEF-dead mutant, β2 cytoplasmic domain mutant) in flow-based leukocyte adhesion assays on endothelium; transendothelial migration assays; ARF6 dominant-negative rescue |
Current biology : CB |
Medium |
11747824
|
| 2002 |
Cybr (a cytokine-inducible protein related to GRASP) physically interacts with cytohesin-1 via coiled-coil domain interactions and enhances cytohesin-1-catalyzed GTPγS binding to ARF in vitro. |
Co-immunoprecipitation of overexpressed proteins from 293T cells; in vitro ARF GEP activity assay with recombinant Cybr |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
11867758
|
| 2003 |
LFA-1 activation induces phosphorylation of the β2 integrin chain, releases JAB-1, and mediates ERK1/2 signaling through cytohesin-1; dominant-negative cytohesin-1 inhibits IL-2 production and impairs Th1 differentiation. |
Intracellular phosphoprotein staining with 13-dimensional flow cytometry; dominant-negative cytohesin-1 expression; cytokine production assays |
Nature immunology |
Medium |
14528303
|
| 2005 |
CD14-regulated complement receptor 3 (CR3/Mac-1)-dependent phagocytosis of mycobacteria requires cytohesin-1; cytohesin-1 physically associates with CR3 upon stimulation with mycobacterial surface components; knockdown of cytohesin-1 specifically abrogates CD14-regulated CR3-mediated BCG internalization. |
siRNA knockdown of cytohesin-1; PI3K inhibitors; blocking antibodies; flow cytometry phagocytosis assay; co-immunoprecipitation of CR3 and cytohesin-1 |
Journal of immunology |
Medium |
15778383
|
| 2009 |
Cytohesin-1 specifically activates Arf6 (but not Arf1) in fMLP-stimulated human neutrophils; cytohesin-1/Arf6 signaling drives phospholipase D activation, NADPH oxidase-dependent superoxide production, and degranulation; SecinH3 (selective cytohesin Sec7 inhibitor) blocks these responses, as does cytohesin-1 siRNA knockdown. |
SecinH3 pharmacological inhibition; siRNA knockdown; stable overexpression in PLB-985 cells; Arf6 and Arf1 activation assays; PLD activity assay; superoxide production assay; surface granule marker expression by flow cytometry |
Journal of immunology |
High |
20018626
|
| 2012 |
The Src-family kinase Fyn phosphorylates cytohesin-1 at tyrosine 382 (Y382); this phosphorylation is required for full myelination by Schwann cells. Transgenic mice expressing a Schwann cell-specific Y382F phosphorylation-deficient cytohesin-1 show delayed myelination and reduced myelin thickness similar to cytohesin-1 knockout mice. |
In vitro kinase assay (Fyn + cytohesin-1); phosphorylation-deficient transgenic mice (Y382F, Schwann cell-specific); cytohesin-1 knockout mice; electron microscopy of peripheral nerves |
Science signaling |
High |
23012656
|
| 2013 |
Cytohesin-1 and its downstream GTPase Arf6 are required for peripheral neuronal conditioned medium-stimulated migration of primary Schwann cells; the Y382 residue (Fyn phosphorylation site) is required for migration since Y382F cytohesin-1 fails to rescue migration in siRNA-transfected cells. |
siRNA knockdown of cytohesin-1 and Arf6; SecinH3 inhibitor; cytohesin-1 knockout Schwann cells; reintroduction of siRNA-resistant wild-type vs. Y382F cytohesin-1; transwell migration assay |
Cellular signalling |
Medium |
23517829
|
| 2013 |
Schwann cell-specific overexpression of wild-type cytohesin-1 in transgenic mice produces enhanced myelin thickness in peripheral nerves and elevated downstream Arf6 activation, confirming cytohesin-1 promotes myelination in vivo through the cytohesin-1/Arf6 signaling axis. |
Schwann cell-specific transgenic overexpression of cytohesin-1; electron microscopy morphometry of peripheral nerves; Arf6 activation assay |
Journal of molecular neuroscience |
Medium |
23636892
|
| 2016 |
CYTH1 knockdown disrupts adhesion of human cord blood hematopoietic stem and progenitor cells (HSPCs) to mesenchymal stroma cells, fibronectin, and ICAM-1/2, reduces integrin β1 activation, impairs bone marrow homing after transplantation into immunodeficient mice, and impairs HSPC lodgment in the marrow niche as shown by intravital microscopy. |
RNAi screen; shRNA knockdown; adhesion assays; integrin β1 activation assay; xenograft transplantation; intravital microscopy |
Blood |
High |
27899358
|
| 2018 |
A microexon-encoded triglycine vs. diglycine difference in the cytohesin-1 PH domain determines differential phosphoinositide affinity (triglycine for PI(4,5)P2, diglycine for PI(3,4,5)P3); this distinction produces distinct subcellular localizations (triglycine to plasma membrane, diglycine to leading edge) and controls Met RTK-dependent cell migration, where the diglycine/PI(3,4,5)P3-binding isoform is specifically required. |
Alternative splicing microexon analysis; phosphoinositide binding assays; live-cell imaging of GFP-tagged isoforms; HGF/Met-stimulated migration assays; isoform-specific knockdown and rescue |
The Journal of cell biology |
High |
30404949
|
| 2023 |
CYTH1 depletion or inhibition with SecinH3 inhibits adhesion, migration, homing, and engraftment of AML leukemic cells in vivo; targeting CYTH1 suppresses integrin-associated adhesion signaling by reducing ITGB2 expression and reduces anti-apoptotic MCL1; SecinH3 synergizes with BCL2-inhibitor venetoclax in ABT-199-resistant AML cells. |
CYTH1 shRNA knockdown; SecinH3 pharmacological inhibition; AML cell line proliferation and apoptosis assays; AML xenograft mouse model; Western blotting for signaling components |
Acta pharmacologica Sinica |
Medium |
37644132
|